Marex Group plc Ordinary Shares (MRX)

FairStock Score: 65/100 — STEADY

Key Financials

Strengths

• High return on equity of 27.5% demonstrating efficient capital deployment
• Revenue growth of 26.9% demonstrates strong top-line momentum

Concerns

• High leverage at 9.88x debt-to-equity increases financial risk and interest expense burden
• Altman Z-Score of 0.3 places it in the financial distress zone—elevated bankruptcy risk

AI Analysis

Marex Group plc Ordinary Shares is a small-cap financial services company valued at $3.7 billion. The business generates $2.9 billion in annual revenue with a 3.0% net margin. From a quality standpoint, Marex shows distressed Altman Z-Score of 0.3 warrants caution and strong 27% ROE. On valuation, the stock is attractively valued at 13.5x earnings, with trades above its Graham Number with a negative 32% margin. Growth dynamics show revenue growing at 26.9% and profit growth of 49.6%. The 1.1% dividend yield adds an income component for patient holders. Our composite FairStock Score of 65/100 reflects above-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Marex's 27% revenue growth trajectory could accelerate as it captures additional market share in the financial services sector. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

Elevated leverage at 9.9x D/E means rising interest rates or revenue weakness could strain debt covenants and force asset sales at distressed prices. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer